660 — Wai Chun Bio Technology Balance Sheet
0.000.00%
Last trade - 00:00
- HK$17.15m
- HK$200.22m
- HK$773.65m
- 28
- 97
- 11
- 40
2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.54 | 5.41 | 5.45 | 7.52 | 6.31 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29.9 | 29 | 14.1 | 50.7 | 42.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 74.4 | 97.3 | 90.2 | 153 | 129 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 42.7 | 78.9 | 98.1 | 97.2 | 111 |
Other Long Term Assets | |||||
Total Assets | 147 | 176 | 188 | 250 | 240 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 158 | 169 | 150 | 178 | 159 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 194 | 226 | 226 | 288 | 275 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -47 | -50.3 | -37.5 | -37.7 | -35 |
Total Liabilities & Shareholders' Equity | 147 | 176 | 188 | 250 | 240 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |